Filing Details
- Accession Number:
- 0001325447-12-000038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-02 13:49:43
- Reporting Period:
- 2012-11-01
- Filing Date:
- 2012-11-02
- Accepted Time:
- 2012-11-02 13:49:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1459450 | Myrexis Inc. | MYRX | Pharmaceutical Preparations (2834) | 263996918 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1325447 | First Eagle Investment Management, Llc | 1345 Avenue Of The Americas New York NY 10105 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.01 Par Value (The "Common Stock") | Disposition | 2012-11-01 | 35,000 | $2.37 | 2,713,617 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
Footnotes
- The shares of Common Stock reported herein are indirectly beneficially owned by First Eagle Investment Management, LLC, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940 ("FEIM"). FEIM is a subsidiary of Arnhold and S. Bleichroeder Holdings, Inc. The shares are held by various clients in accounts under FEIM's management and control. FEIM disclaims beneficial ownership of the shares of Common Stock as provided in Rule 16a-1 and otherwise to the extent such beneficial ownership exceeds its pecuniary interest therein.